Transaction in Own Shares

Summary by AI BETAClose X

RTW Biotech Opportunities Ltd announced on December 2, 2025, that it repurchased 100,000 of its Ordinary Shares on December 1, 2025, for $1.9525 per share. These shares will be held in treasury, reducing the total voting rights to 326,623,649. This buyback was authorized by shareholders at the June 2025 Annual General Meeting, which allows for repurchases up to 14.99% of outstanding shares. The company will not pay a premium to net asset value for these repurchases.

Disclaimer*

UK 100

Latest directors dealings